The PreciseOnco research consortium has been awarded €14.9 million in funding from the European Union’s Innovative ...
The FDA approved Optune Pax (Novocure), a first-in-class portable device that delivers tumor-treating fields (TTFields) to ...
Margaret Krackeler, MD, of Kaiser Permanente Northern California, shares lessons on implementing evidence-based formulary changes for patients with CLL.
Surgery remains one of the most effective treatments for localized cancer. The primary aim is complete tumor removal with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results